Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995

CMAJ. Canadian Medical Association Journal

Volumn 163, Issue 1, 2000, Pages 31-36

  Pilote, Louise ^a   Lavoie, Frédéric ^a   Ho, Vivian ^c   Eisenberg, Mark J ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ARTICLE; CANADA; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MALE; MORTALITY; PRESCRIPTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0034636724     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 1. Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565-72.
2. 2. Pilote L, Racine N, Hlatky MA. Treatment of acute myocardial infarction in the United States and Canada: a comparison of two university hospitals. Arch Intern Med 1994;154:1090-6.
3. 3. Van de Werf F, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW, et al. Variations in patient management and outcomes for acute myocardial infarction in the Unites States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. JAMA 1995;273:1586-91.
4. 4. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variations in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995;333:573-8.
5. 5. Pilote L, Lavoie F, Saynian O, Eisenberg MJ, McLellan M. Procedures and outcomes for the treatment of the elderly with acute myocardial infarction in the United States and Canada between 1988 and 1994 [abstract]. Circulation 1998;98:I-195.
6. 6. Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organization to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1999;352:507-14.
7. 7. Rouleau JL, Moyé LA, Pfeffer MA, Arnold JM, Bernstein V, Cuddy TE, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779-84.
8. 8. Tu JV, Pashos CL, Naylor CD, Chen E, Normand SL, Newhouse JP, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-5.
9. 9. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction in the United States. N Engl J Med 1996;335:1198-205.
10. 10. Pilote L, Granger C, Armstrong PW, Mark DB, Hlatky MA. Differences in the treatment of acute myocardial infarction in the United States and Canada: a physician's survey. Med Care 1995;33:598-610.
11. 11. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, et al. Medical resource and quality of life outcomes following acute myocardial infarction in Canada versus the United States: the Canadian-U.S. GUSTO substudy. N Engl J Med 1994;331:1130-5.
12. 12. Pilote L, Bourassa MG, Bacon C, Hlatky MA. Better functional status in American than in Canadian patients after myocardial infarction: An effect of medical care? J Am Coll Cardiol 1995;26:1115-20.
13. 13. Lamas GA, Pfeffer MA, Hamm P, Wertheimer J, Rouleau JL, Braunwald E. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 1992;327:241-7.
14. 14. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction: lessons from overviews of recent randomized controlled trials. Circulation 1990;82(Suppl):II-117-34.
15. 15. Barron HV, Michaels AD, Maynard C, Every NR. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32;360-7.
16. 16. Viskin S, Kitzis I, Lev E, Zak Z, Heller K, Villa Y, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized clinical trials to clinical practice. J Am Coll Cardiol 1995;25;1327-32.
17. 17. Phillips BG, Yim JM, Brown EJ, Bittar N, Hoon TJ, Celestin C, et al. Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospital. Am Heart J 1996;131:872-8.
18. 18. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998;280:623-9.
19. 19. Tu JV, Naylor CD, Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ 1999;161(10):1257-61.